It is interesting to consider the $338 million/year sales.
The key factor that is missing from the analysis, though, ids Lynas Rare Earths Direct strategy.
They are custom formulating blends, which almost always involves a premium price. We really won't know until the company reports on sales how much this will impact share price.
Having been in the custom formulated chemical industry, sometimes these premiums are small and sometimes they can be quite large. But there is always a premium.
- Forums
- ASX - By Stock
- LYC
- higher valued added
higher valued added
-
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LYC (ASX) to my watchlist
|
|||||
Last
$6.08 |
Change
0.015(0.25%) |
Mkt cap ! $5.655B |
Open | High | Low | Value | Volume |
$6.00 | $6.08 | $5.97 | $5.301M | 878.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 8543 | $6.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.08 | 14725 | 34 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 5569 | 6.070 |
18 | 103317 | 6.060 |
21 | 38034 | 6.050 |
15 | 16988 | 6.040 |
22 | 54460 | 6.030 |
Price($) | Vol. | No. |
---|---|---|
6.080 | 13548 | 34 |
6.090 | 42425 | 23 |
6.100 | 57913 | 24 |
6.110 | 90548 | 10 |
6.120 | 6057 | 4 |
Last trade - 11.29am 25/07/2024 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online